This illness is now the fastest rising cause of cancer deaths in the UK, but only 33% to 50% of cases are diagnosed at an ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025On track to initiate U.S.

Deaths caused by this disease more than tripled between 2017 to 2019 and it is now the fastest rising cause of cancer deaths ...

Liver cancer deaths more than tripled between 2017 and 2019 and the disease is now the fastest rising cause of cancer deaths ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

HEPATITIS C (HCV) poses a severe health threat, particularly among vulnerable populations like people experiencing ...

Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers.

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

OrganOx Ltd., a medical technology company developing innovative solutions for organ preservation, and eGenesis, Inc., a ...